Key result
Systemic chemotherapy successfully treated primary cardiac B-cell lymphoma, leading to the complete resolution of atrial fibrillation and bradycardia and restoration of normal sinus rhythm.
Case Report (n=1)
No
Primary cardiac lymphoma is a rare but potentially reversible cause of atrial fibrillation if treated promptly with chemotherapy.
Answers are grounded in this paper and cite their sources.
Chemotherapy may reverse AF in primary cardiac lymphoma; leaves open prospective validation in larger cohorts.
Primary cardiac lymphoma (PCL) only rarely occurs and it is defined as a lymphoma in which the bulk of the tumor is located within the heart and pericardium. A 53-year-old woman was referred due to dyspnea, and an electrocardiogram exhibited atrial fibrillation (AF). Echocardiography revealed no abnormal findings. Scintigraphy and a lymph node biopsy led to a diagnosis of PCL. After the start of chemotherapy, AF was converted to atrial tachycardia prior to sinus rhythm with a first-degree atrioventricular block, which was finally restored to a normal sinus rhythm. PCL is only rarely encountered, but it should be included in the differential diagnosis as a possible cause of AF, and such AF could be reversible if the patient can be treated in a timely manner.
No takes yet. Share an insight, caveat, or question.
Hishikari et al. (2016) conducted a case report in Primary Cardiac B-Cell Lymphoma (n=1). Systemic chemotherapy was evaluated on Restoration of normal sinus rhythm and tumor regression. Systemic chemotherapy successfully treated primary cardiac B-cell lymphoma, leading to the complete resolution of atrial fibrillation and bradycardia and restoration of normal sinus rhythm.
Synapse has enriched 10 related papers. Consider them for comparative context: